论文信息 - Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development. - 字舞流文

Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development.

M. Mason | J. Balzarini | C. Mcguigan | S. Blagden | E. Ghazaly | W. Jiang | Magdalena Ślusarczyk | Emely Thompson | M. Lopez | C. Mcguigan*